Glenmark Pharmaceuticals has received final approval from the US health regulator for generic Diclofenac Sodium gel used for treatment of skin lesions.“Glenmark Pharmaceuticals Inc USA has been grant...
This is an update of the announcement from 09:02 13.09.2016 BST. Reason for
update: amended period of stabilisation date
13th September 2016
Not for distribution, directly or indirectly, in or into the United States or